Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec 12:15:116.
doi: 10.1186/s12935-015-0269-y. eCollection 2015.

Arsenic trioxide reduces chemo-resistance to 5-fluorouracil and cisplatin in HBx-HepG2 cells via complex mechanisms

Affiliations

Arsenic trioxide reduces chemo-resistance to 5-fluorouracil and cisplatin in HBx-HepG2 cells via complex mechanisms

Guifang Yu et al. Cancer Cell Int. .

Abstract

Background: Multidrug resistance is one of the major reasons chemotherapy-based treatments failed in hepatitis B virus (HBV) related hepatocellular carcinoma (HCC). Hypoxia is generally associated with tumor chemo-resistance. The aim of the study was to investigate the effect of Arsenic trioxide (As2O3) on the hypoxia-induced chemo-resistance to 5-FU or cisplatin and explored its underlying mechanism in the HBx-HepG2 cells.

Methods: MTT assay was used to examine the cell viability. Mitochondrial membrane potential (MMP) and cell cycle was examined by flow cytometry. qRT-PCR was employed to observe the mRNA expression level; and western blot assay was used to determine the protein expression level.

Results: Our results showed that transfection of HBx plasmid established the HBx-HepG2 cells expressing HBx, and the expression of HBx was confirmed by qRT-PCR and western blot. Exposure of HBx-HepG2 cells to hypoxia (5 % O2, 3 % O2, 1 % O2) for 48 h increased the chemo-resistance to 5-fluorouracil (5-FU) (50-1600 µM) and cisplatin (25-800 µM), reduced MMP, and caused the cell cycle arrest at G0/G1 phase in a concentration-dependent manner. Hypoxia also concentration-dependently (5 % O2, 3 % O2, 1 % O2) reduced mRNA expression level of P-glycoprotein (P-gp), multidrug resistance protein (MRP1), lung resistance protein (LRP), and decreased the protein expression level of hypoxia-inducible factor-1α (HIF-1α), P-gp MRP1, and LRP. Following pretreatment with As2O3 at a non-cytotoxic concentration re-sensitized the hypoxia (1 % O2)-induced chemo-resistance to 5-FU and cisplatin in HBx-HepG2 cells. As2O3 pretreatment also prevented MMP reduction and G0/G1 arrest induced by hypoxia. Meanwhile, As2O3 antagonized increase of HIF-1α protein induced by hypoxia, and it also suppresses the increase in expression levels of P-gp, MRP1, and LRP mRNA and proteins. In addition, As2O3 in combination with 5-FU treatment caused up-regulation of DR5, caspase 3, caspase 8, and caspase 9, and down-regulation of BCL-2, but had no effect of DR4.

Conclusions: Our results may suggest that As2O3 re-sensitizes hypoxia-induced chemo-resistance in HBx-HepG2 via complex pathways, and As2O3 may be a potential agent that given in combination with other anti-drugs for the treatment of HBV related HCC, which is resistant to chemotherapy.

Keywords: 5-FU; Chemo-resistance; Cisplatin; HBV; HBx-HepG2; HCC; HIF-1α; LRP; MRP1; P-gp.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Establishment of HepG2-HBx cell lines. qRT-PCR and western blot were used to evaluate the expression levels of HBx mRNA and protein in empty vector-transfected HepG2 cells, HBx-transfected HepG2 cells and HepG2.2.15 cells. All data were expressed as mean ± s.e.m., n = 4
Fig. 2
Fig. 2
Effect of hypoxia on the cell viability of HBX-HepG2 cells treated with chemotherapeutic agents and on the mitochondrial membrane potential (MMP) in HBX-HepG2 cells. MTT assay was conducted on HBX-HepG2 cells pre-incubated for 48 h in normoxic (21 % O2) or hypoxic (5 % O2, 3 % O2, or 1 % O2) conditions and subsequently treated with a 5-FU (50–1600 µM) or b Cisplatin (25–800 µM); c flow-cytometry was conducted on HBx-HepG2 cells pre-incubated for 48 h in normoxic (21 % O2) or hypoxic (5 % O2, 3 % O2, or 1 % O2) conditions to measure the MMP. All data were expressed as mean ± s.e.m., n = 4; significant differences between hypoxia (1 % O2) group and normoxia group were indicated as *P < 0.05, **P < 0.01, ***P < 0.001; significantly differences between hypoxia (3 % O2) group and normoxia group were indicated as # P < 0.05 (One-way ANOVA followed by Bonferroni’s multiple comparison tests)
Fig. 3
Fig. 3
Effect of hypoxia on expression levels of P-gp, MRP1 and LRP mRNA inHBX-HepG2 cells. qRT-PCR assay was conducted on HBx-HepG2 cells pre-incubated for 48 h in normoxic (21 % O2) or hypoxic (5 % O2, 3 % O2, or 1 % O2) to measure the expression levels of a P-gp, b MRP1 and c LRP mRNA. All data were expressed as mean ± s.e.m., n = 4; significant differences between hypoxia (1 % O2) group and normoxia group were indicated as **P < 0.01, ***P < 0.001; significant differences between hypoxia (3 % O2) group and normoxia group were indicated as # P < 0.05; ## P < 0.01 (One-way ANOVA followed by Bonferroni’s multiple comparison tests)
Fig. 4
Fig. 4
Effect of hypoxia on expression levels of HIF-1α, P-gp, MRP1 and LRP protein in HBx-HepG2 cells. Western blot assay was conducted on HBX-HepG2 cells pre-incubated for 48 h in normoxic (21 % O2) or hypoxic (5 % O2, 3 % O2, or 1 % O2) conditions to measure the expression levels of HIF-1α, P-gp, MRP1 and LRP protein, band densities were normalized to β-actin. All data were expressed as mean ± s.e.m., n = 4; significant differences between hypoxia (1 % O2) group and normoxia group were indicated as *P < 0.05, **P < 0.01; significantly differences between hypoxia (3 % O2) group and normoxia group were indicated as # P < 0.05 (One-way ANOVA followed by Bonferroni’s multiple comparison tests)
Fig. 5
Fig. 5
Effect of As2O3 (1 µM) on chemo-sensitivity, MMP, and cell cycle of HBx-HepG2 cells pretreated with hypoxia (1 % O2). MTT assay was used to evaluate the effect of As2O3 on chemo-sensitivity to a 5-FU (50–1600 µM) or b cisplatin (25–800 µM) in HBx-HepG2 cells pretreated with 48 h hypoxia (1 % O2); c flow-cytometry was used to examine the effect of As2O3 on MMP in HBx-HepG2 cells pretreated with 48 h hypoxia (1 % O2); d flow-cytometry was used to examine the effect of As2O3 on MMP in HBx-HepG2 cells pretreated with 48 h hypoxia (1 % O2). All data were expressed as mean ± s.e.m., n = 4; ATO = As2O3; significant differences between hypoxia (1 % O2) group and hypoxia (1 % O2) + ATO group were indicated as *P < 0.05, **P < 0.01, ***P < 0.001 (unpaired t-test)
Fig. 6
Fig. 6
Effect of As2O3 (1 µM) on the expression levels of P-gp, MRP1 and LRP mRNA inHBx-HepG2 cells pretreated with hypoxia (1 % O2). qRT-PCR assay was used to examine the effect of As2O3 on the expression levels of a P-gp, b MRP1 and c LRP mRNA in HBx-HepG2 cells pretreated with hypoxia (1 % O2). All data were expressed as mean ± s.e.m., n = 4; significantly differences between hypoxia (1 % O2) group and hypoxia (1 % O2) + ATO group were indicated as *P < 0.05, **P < 0.01 (unpaired t-test)
Fig. 7
Fig. 7
Effect of As2O3 (1 µM) on the expression levels of P-gp, MRP1 and LRP protein in HBx-HepG2 cells pretreated with hypoxia (1 % O2). Western blot assay was used to examine the effect of As2O3 on the expression levels of P-gp, MRP1 and LRP protein in HBx-HepG2 cells pretreated with hypoxia (1 % O2), band densities were normalized to β-actin. All data were expressed as mean ± s.e.m., n = 4; significant differences between hypoxia (1 % O2) group and hypoxia (1 % O2) + ATO group were indicated as *P < 0.05, **P < 0.01 (unpaired t-test)
Fig. 8
Fig. 8
Effect of As2O3 (1 µM) + 5-FU (400 µM) on the expression levels of apoptotic-related factors protein in HBx-HepG2 cells pretreated with hypoxia (1 % O2). Western blot assay was used to examine the effect of As2O3 + 5-FU on the expression levels of DR4, DR5, BCL-2, caspase 3, caspase 8 and caspase 9 protein in HBx-HepG2 cells pretreated with hypoxia (1 % O2), band densities were normalized to β-actin. All data were expressed as mean ± s.e.m., n = 4; significant differences between Ctrl + 5-FU group and ATO + 5-FU group were indicated as *P < 0.05 (unpaired t-test)

References

    1. Sinn DH, Lee J, Goo J, Kim K, Gwak GY, Paik YH, Choi MS, Lee JH, Koh KC, Yoo BC, et al. Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load. Baltimore: Hepatology; 2015. - PubMed
    1. Liu XY, Tang SH, Wu SL, Luo YH, Cao MR, Zhou HK, Jiang XW, Shu JC, Bie CQ, Huang SM, et al. Epigenetic modulation of insulin-like growth factor-II overexpression by hepatitis B virus X protein in hepatocellular carcinoma. Am J cancer Res. 2015;5(3):956–978. - PMC - PubMed
    1. Yin D, Huang P, Zhuang B, Zhang H, Yan H, Xiao Z, Li W, Zhang J, Tang Q, Hu K, et al. Hepatitis B virus X protein (HBx) is responsible for resistance to targeted therapies in hepatocellular carcinoma: ex vivo culture evidence. Clin Cancer Res. 2015;21(49):4420–4430. - PubMed
    1. Koike K. Hepatocarcinogenesis in hepatitis viral infection: lessons from transgenic mouse studies. J Gastroenterol. 2002;37(Suppl 13):55–64. doi: 10.1007/BF02990101. - DOI - PubMed
    1. Chami M, Ferrari D, Nicotera P, Paterlini-Brechot P, Rizzuto R. Caspase-dependent alterations of Ca2+ signaling in the induction of apoptosis by hepatitis B virus X protein. J Biol Chem. 2003;278(34):31745–31755. doi: 10.1074/jbc.M304202200. - DOI - PubMed